Can a new pill silence the itch of chronic hives?

NCT ID NCT05107115

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial is testing whether an experimental oral drug called rilzabrutinib can reduce the itching and hives in adults with chronic spontaneous urticaria (CSU) — a condition where hives appear without a clear trigger — even when standard antihistamines haven't helped. Participants will receive one of three doses of rilzabrutinib or a placebo for 12 weeks, and those who finish may continue on the drug for up to 40 more weeks. The study tracks changes in itch and hive severity to see if the drug offers meaningful relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
rilzabrutinib
What this could lead to
If rilzabrutinib works, it could offer a new oral treatment option for people with chronic hives that don't respond to antihistamines, potentially reducing itch and hive severity.
What could go wrong
This is an early-phase trial, so the drug may not prove more effective than placebo. Possible side effects are still being evaluated, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Investigational Site Number : 0320001

    Buenos Aires, C1121ABE, Argentina

  • Investigational Site Number : 0320002

    CABA, Buenos Aires, C1414AIF, Argentina

  • Investigational Site Number : 0320003

    Rosario, Santa Fe Province, S2000JKR, Argentina

  • Investigational Site Number : 0320004

    Rosario, Santa Fe Province, 2000, Argentina

  • Investigational Site Number : 0320005

    Rosario, Santa Fe Province, 2000, Argentina

  • Investigational Site Number : 0320006

    CABA, Buenos Aires, C1055AAO, Argentina

  • Investigational Site Number : 1240002

    Trois-Rivières, Quebec, G8T 7A1, Canada

  • Investigational Site Number : 1240003

    Québec, G1V 4W2, Canada

  • Investigational Site Number : 1240004

    Toronto, Ontario, M5G 1E2, Canada

  • Investigational Site Number : 1240005

    Toronto, Ontario, M3B 3S6, Canada

  • Investigational Site Number : 1240006

    Montreal, Quebec, H4A 3T2, Canada

  • Investigational Site Number : 1240009

    Red Deer, Alberta, T4P 1K4, Canada

  • Investigational Site Number : 1520001

    Santiago, Reg Metropolitana de Santiago, 7640881, Chile

  • Investigational Site Number : 1520002

    Santiago, Reg Metropolitana de Santiago, 8420383, Chile

  • Investigational Site Number : 1520004

    Osorno, Los Lagos Region, 5310644, Chile

  • Investigational Site Number : 1580001

    Taipei, 10002, Taiwan

  • Investigational Site Number : 1580002

    Hsinchu, 30059, Taiwan

  • Investigational Site Number : 1580003

    Taichung, 40201, Taiwan

  • Investigational Site Number : 1580004

    Kaohsiung City, 833, Taiwan

  • Investigational Site Number : 2760001

    Dresden, 01307, Germany

  • Investigational Site Number : 2760002

    Berlin, 12200, Germany

  • Investigational Site Number : 2760004

    Mainz, 55131, Germany

  • Investigational Site Number : 2760005

    Kiel, 24105, Germany

  • Investigational Site Number : 3000001

    Athens, 12462, Greece

  • Investigational Site Number : 3000002

    Athens, 16121, Greece

  • Investigational Site Number : 3000003

    Thessaloniki, 56403, Greece

  • Investigational Site Number : 3000004

    N. Efkarpia, 56429, Greece

  • Investigational Site Number : 3800001

    Milan, Lombardy, 20122, Italy

  • Investigational Site Number : 3800002

    Ancona, 60126, Italy

  • Investigational Site Number : 3800005

    Catania, Italy

  • Investigational Site Number : 3920001

    Sagamihara-shi, Kanagawa, 252-0392, Japan

  • Investigational Site Number : 3920002

    Sapporo, Hokkaido, 063-0005, Japan

  • Investigational Site Number : 3920003

    Tachikawa-shi, Tokyo, 190-0014, Japan

  • Investigational Site Number : 3920004

    Nagoya, 454-8509, Japan

  • Investigational Site Number : 3920005

    Chikushino-shi, Fukuoka, 818-0083, Japan

  • Investigational Site Number : 3920006

    Izumo-shi, Shimane, 693-8501, Japan

  • Investigational Site Number : 3920007

    Yokohama, Kanagawa, 221-0825, Japan

  • Investigational Site Number : 4100002

    Busan, Busan, 49241, South Korea

  • Investigational Site Number : 4100003

    Seoul, Seoul-teukbyeolsi, 06973, South Korea

  • Investigational Site Number : 4100004

    Yeongdeunpo-gu, Seoul-teukbyeolsi, Hyllm University Med, South Korea

  • Investigational Site Number : 4100005

    Ansan-si, Gyeonggi-do, 15355, South Korea

  • Investigational Site Number : 5280001

    Utrecht, 3584 CX, Netherlands

  • Investigational Site Number : 5280002

    Rotterdam, 3015 GD, Netherlands

  • Investigational Site Number : 6160001

    Gdansk, Pomeranian Voivodeship, 80-214, Poland

  • Investigational Site Number : 6160004

    Krakow, 31-011, Poland

  • Investigational Site Number : 6160005

    Lodz, 91-211, Poland

  • Investigational Site Number : 6160006

    Wroclaw, 50-566, Poland

  • Investigational Site Number : 6160007

    Wroclaw, Lower Silesian Voivodeship, 53-673, Poland

  • Investigational Site Number : 6160008

    Krakow, 30-438, Poland

  • Investigational Site Number : 6160009

    Gdansk, Pomeranian Voivodeship, 80-546, Poland

  • Investigational Site Number : 6430001

    Stavropol, 355020, Russia

  • Investigational Site Number : 6430002

    Moscow, 123182, Russia

  • Investigational Site Number : 6430005

    Moscow, 115522, Russia

  • Investigational Site Number : 7240001

    Barcelona, Barcelona [Barcelona], 08003, Spain

  • Investigational Site Number : 7240002

    Córdoba, 14004, Spain

  • Investigational Site Number : 7240004

    Seville, Andalusia, 41009, Spain

  • Investigational Site Number : 7240005

    Alicante, 03010, Spain

  • Investigational Site Number : 7240006

    Pamplona, Navarre, 31008, Spain

  • Investigational Site Number : 7240008

    Barcelona / Sabadell, Catalunya [Cataluña], 08208, Spain

  • Investigational Site Number :0320001

    Buenos Aires, C1121ABE, Argentina

  • Investigational Site Number :0320002

    CABA, Buenos Aires, C1414AIF, Argentina

  • Investigational Site Number :0320003

    Rosario, Santa Fe Province, S2000JKR, Argentina

  • Investigational Site Number :0320004

    Rosario, Santa Fe Province, 2000, Argentina

  • Investigational Site Number :0320005

    Rosario, Santa Fe Province, 2000, Argentina

  • Investigational Site Number :0320006

    CABA, Buenos Aires, C1055AAO, Argentina

  • Investigational Site Number :1240002

    Trois-Rivières, Quebec, G8T 7A1, Canada

  • Investigational Site Number :1240003

    Québec, G1V 4W2, Canada

  • Investigational Site Number :1240004

    Toronto, Ontario, M5G 1E2, Canada

  • Investigational Site Number :1240005

    Toronto, Ontario, M3B 3S6, Canada

  • Investigational Site Number :1240006

    Montreal, Quebec, H4A 3T2, Canada

  • Investigational Site Number :1240009

    Red Deer, Alberta, T4P 1K4, Canada

  • Investigational Site Number :1240010

    Calgary, Alberta, T2W 4X9, Canada

  • Investigational Site Number :1520001

    Santiago, Reg Metropolitana de Santiago, 7640881, Chile

  • Investigational Site Number :1520002

    Santiago, Reg Metropolitana de Santiago, Chile

  • Investigational Site Number :1520003

    Santiago, Reg Metropolitana de Santiago, 7750000, Chile

  • Investigational Site Number :1520004

    Osorno, Los Lagos Region, 5310644, Chile

  • Investigational Site Number :1580001

    Taipei, 10002, Taiwan

  • Investigational Site Number :1580002

    Hsinchu, 30059, Taiwan

  • Investigational Site Number :1580003

    Taichung, 402, Taiwan

  • Investigational Site Number :1580004

    Kaohsiung City, 833, Taiwan

  • Investigational Site Number :2760001

    Dresden, 01307, Germany

  • Investigational Site Number :2760002

    Berlin, 10117, Germany

  • Investigational Site Number :2760004

    Mainz, 55131, Germany

  • Investigational Site Number :2760005

    Kiel, 24105, Germany

  • Investigational Site Number :3000001

    Athens, 12462, Greece

  • Investigational Site Number :3000002

    Athens, 16121, Greece

  • Investigational Site Number :3000003

    Thessaloniki, 56429, Greece

  • Investigational Site Number :3000004

    N. Efkarpia, 56429, Greece

  • Investigational Site Number :3800001

    Milan, Lombardy, 20122, Italy

  • Investigational Site Number :3800002

    Ancona, 60126, Italy

  • Investigational Site Number :3800004

    Milan, Lombardy, 20161, Italy

  • Investigational Site Number :3800005

    Catania, Italy

  • Investigational Site Number :3920001

    Sagamihara-shi, Kanagawa, 252-0392, Japan

  • Investigational Site Number :3920002

    Sapporo, Hokkaido, 063-0005, Japan

  • Investigational Site Number :3920003

    Tachikawa-shi, Tokyo, 190-0014, Japan

  • Investigational Site Number :3920004

    Nagoya, Aichi-ken, 454-8509, Japan

  • Investigational Site Number :3920005

    Chikushino-shi, Fukuoka, 818-0083, Japan

  • Investigational Site Number :3920006

    Izumo-shi, Shimane, 693-8501, Japan

  • Investigational Site Number :3920007

    Yokohama, Kanagawa, 221-0825, Japan

  • Investigational Site Number :4100001

    Seoul, Seoul-teukbyeolsi, 03080, South Korea

  • Investigational Site Number :4100002

    Busan, Busan, 602-739, South Korea

  • Investigational Site Number :4100003

    Seoul, Seoul-teukbyeolsi, 06973, South Korea

  • Investigational Site Number :4100004

    Yeongdeunpo-gu, Seoul-teukbyeolsi, Hyllm University Med, South Korea

  • Investigational Site Number :4100005

    Ansan-si, Gyeonggi-do, 15355, South Korea

  • Investigational Site Number :5280001

    Utrecht, 3584 CX, Netherlands

  • Investigational Site Number :5280002

    Rotterdam, 3015 GD, Netherlands

  • Investigational Site Number :6160001

    Gdansk, Pomeranian Voivodeship, 80-214, Poland

  • Investigational Site Number :6160003

    Krakow, 31-302, Poland

  • Investigational Site Number :6160004

    Krakow, 31-011, Poland

  • Investigational Site Number :6160005

    Lodz, 91-211, Poland

  • Investigational Site Number :6160006

    Wroclaw, 50-566, Poland

  • Investigational Site Number :6160007

    Wroclaw, Lower Silesian Voivodeship, 50-088, Poland

  • Investigational Site Number :6160008

    Krakow, 30-438, Poland

  • Investigational Site Number :6160009

    Gdansk, Pomeranian Voivodeship, 80-546, Poland

  • Investigational Site Number :6430001

    Stavropol, 355020, Russia

  • Investigational Site Number :6430002

    Moscow, 123182, Russia

  • Investigational Site Number :6430003

    Saint Petersburg, 193231, Russia

  • Investigational Site Number :6430004

    Smolensk, 214006, Russia

  • Investigational Site Number :6430005

    Moscow, 115522, Russia

  • Investigational Site Number :6430006

    Moscow, 115522, Russia

  • Investigational Site Number :7240001

    Barcelona, Barcelona [Barcelona], 08003, Spain

  • Investigational Site Number :7240002

    Córdoba, 14004, Spain

  • Investigational Site Number :7240003

    Pamplona, Navarre, 31008, Spain

  • Investigational Site Number :7240004

    Seville, Andalusia, 41009, Spain

  • Investigational Site Number :7240005

    Alicante, 03010, Spain

  • Investigational Site Number :7240006

    Pamplona, Navarre, 31008, Spain

  • Investigational Site Number :7240007

    Pozuelo de Alarcón, Madrid, 28223, Spain

  • Investigational Site Number :7240008

    Barcelona / Sabadell, Catalunya [Cataluña], 08208, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.